Patents by Inventor Viviane Machado De Mello Andrade

Viviane Machado De Mello Andrade has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230340033
    Abstract: Disclosed herein are nucleic acid molecules encoding a Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) spike antigen, SARS-CoV-2 spike antigens, immunogenic compositions, and vaccines and their use in inducing immune responses and protecting against or treating a SARS-CoV-2 infection in a subject.
    Type: Application
    Filed: April 14, 2023
    Publication date: October 26, 2023
    Inventors: Kate Broderick, Trevor Smith, Richa Kalia, Viviane Machado de Mello Andrade
  • Publication number: 20220331421
    Abstract: Disclosed herein are methods of administering and uses of a plasmid encoding residues 19-1279 of SEQ ID NO: 1, a plasmid comprising nucleotides 55-3837 of SEQ ID NO: 2, pGX9501, INO-4800 drug product, or a biosimilar thereof to induce an immune response against Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) variant B.1.351, SARS-CoV-2 variant B.1.1.7, SARS-CoV-2 variant P.1, SARS-CoV-2 variant B.1.617.1, SARS-CoV-2 variant B.1.617.2, or SARS-CoV-2 variant B.1.1.529.
    Type: Application
    Filed: April 13, 2022
    Publication date: October 20, 2022
    Inventors: Trevor Smith, Stephanie Ramos, Viviane Machado De Mello Andrade